Professor Duncan Jodrell, DM MSc FRCP(Edin.) – Researcher and Medical Oncologist, co-lead
Duncan is the Professor of Cancer Therapeutics at the University of Cambridge and a Senior Group Leader at the Cancer Research UK Cambridge Institute. He is also the Cambridge Experimental Cancer Medicine Centre (ECMC) Lead, Director of the Cambridge Cancer Trials Centre (CCTC) and an honorary consultant at Addenbrooke’s Hospital
Dr. Giulia Biffi, co-lead
Giulia Biffi is a group leader at the Cancer Research UK Cambridge Institute, University of Cambridge. Her laboratory works to understand the biology of pancreatic cancer, with aim of identifying more effective treatments for patients.
Professor Ashok Venkitaraman, Ursula Zoellner Professor; Director, MRC Cancer Cell Unit
Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.
Dr. Martin L Miller MSc PhD
Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.
Dr. Frances Richards
Frances Richards is the Pharmacology & Drug Development Group (Jodrell Group) Lab Head in the Cancer Research UK Cambridge Institute. With a background in cancer genetics and in drug discovery, she leads research projects focussed on preclinical development of drug combinations for treatment of pancreatic cancer.
Dr. Tim Halim
Tim is a group leader at the Cancer Research UK – Cambridge Institute, University of Cambridge. The Halim laboratory focusses on innate lymphoid cell (ILC) biology, and how innate immunity interacts locally with immune and non-immune cells in the pancreas.
Professor Jason CarrollJason Carroll is a Professor of Molecular Oncology at the University of Cambridge, a Senior Group Leader at Cancer Research UK, a Fellow at Clare College and was elected an EMBO member in 2016 and a Fellow of the Academy of Medical Sciences in 2017. His lab is interested in understanding mechanisms of hormone-dependent cancer.
Dr. Trevor Littlewood – Research scientistTrevor co-runs (with Professor Gerard Evan) an academic research group at the University of Cambridge, department of biochemistry. Trevor’s interest in oncogenic signalling started at the Ludwig Institute for Cancer Research in the late 1980s and continued at the Imperial Cancer Research Fund (now CR UK), the MRC laboratory of Medical Biology and, since 2010, at the department of biochemistry.
Professor George MalliarasGeorge Malliaras is the Prince Philip Professor of Technology at the University of Cambridge. He is leading the EPSRC IRC on Targeted Delivery for Hard-to-Treat Cancers and works on electrophoretic drug delivery devices.
Dr. Michael (Mike) Gill
Mike is a Principle Scientific Associate in the Miller lab at the Cancer research UK- Cambridge Institute, University of Cambridge. My main research focus is centred around understanding the intercellular communication between heterogeneous pancreatic tumour cells, fibroblasts and macrophages, using multiple omics technologies.